{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:52:52Z","timestamp":1782226372892,"version":"3.54.5"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T00:00:00Z","timestamp":1757721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T00:00:00Z","timestamp":1757721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"UMCU, Strategic Program Cancer Boost grant"},{"name":"TKI-Health Holland"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-025-04164-3","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T08:13:49Z","timestamp":1757751229000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["High-plex imaging of hepatoblastoma and adjacent liver in pediatric patients reveals a predominant myeloid infiltrate expressing immune-checkpoints"],"prefix":"10.1007","volume":"74","author":[{"given":"Dani\u00eblle","family":"Krijgsman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianne J.","family":"Kraaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristof","family":"van Avondt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meggy E. L.","family":"Verdonschot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette H. W.","family":"Leusen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius C.","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben H.","family":"de Kleine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent E.","family":"de Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathelijne C. J.","family":"Kraal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald R.","family":"de Krijger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f3zsef","family":"Zsiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weng Chuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Vercoulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,13]]},"reference":[{"key":"4164_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejca.2015.09.023","volume":"52","author":"P Czauderna","year":"2016","unstructured":"Czauderna P, Haeberle B, Hiyama E et al (2016) The children\u2019s hepatic tumors international collaboration (CHIC): novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model. Eur J Cancer 52:92\u2013101. https:\/\/doi.org\/10.1016\/j.ejca.2015.09.023","journal-title":"Eur J Cancer"},{"key":"4164_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3390\/children9040525","volume":"9","author":"MB Klunder","year":"2022","unstructured":"Klunder MB, Bruggink JLM, Huynh LDH et al (2022) Surgical outcome of children with a malignant liver tumour in the Netherlands: a retrospective consecutive cohort study. Children (Basel) 9:525. https:\/\/doi.org\/10.3390\/children9040525","journal-title":"Children (Basel)"},{"key":"4164_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/cncr.33848","volume":"128","author":"AJM Meijer","year":"2022","unstructured":"Meijer AJM, Li KH, Brooks B et al (2022) The cumulative incidence of cisplatin-induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments. Cancer 128:169\u2013179. https:\/\/doi.org\/10.1002\/cncr.33848","journal-title":"Cancer"},{"issue":"8","key":"4164_CR4","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1158\/2159-8290.CD-22-0120","volume":"12","author":"EJM Bertrums","year":"2022","unstructured":"Bertrums EJM, Rosendahl Huber AKM, de Kanter JK et al (2022) Elevated mutational age in blood of children treated for cancer contributes to therapy-related myeloid neoplasms. Cancer Discov 12(8):1860\u20131872. https:\/\/doi.org\/10.1158\/2159-8290.CD-22-0120","journal-title":"Cancer Discov"},{"key":"4164_CR5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S1470-2045(16)30598-8","volume":"18","author":"RL Meyers","year":"2017","unstructured":"Meyers RL, Maibach R, Hiyama E et al (2017) Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children\u2019s Hepatic tumors International Collaboration. Lancet Oncol 18:122\u2013131. https:\/\/doi.org\/10.1016\/S1470-2045(16)30598-8","journal-title":"Lancet Oncol"},{"key":"4164_CR6","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S1470-2045(13)70272-9","volume":"14","author":"J Zsiros","year":"2013","unstructured":"Zsiros J, Brugieres L, Brock P et al (2013) Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. Lancet Oncol 14:834\u2013842. https:\/\/doi.org\/10.1016\/S1470-2045(13)70272-9","journal-title":"Lancet Oncol"},{"key":"4164_CR7","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1056\/NEJMoa0810613","volume":"361","author":"G Perilongo","year":"2009","unstructured":"Perilongo G, Maibach R, Shafford E et al (2009) Cisplatin versus Cisplatin plus Doxorubicin for standard-risk hepatoblastoma. N Engl J Med 361:1662\u20131670. https:\/\/doi.org\/10.1056\/NEJMoa0810613","journal-title":"N Engl J Med"},{"key":"4164_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108387","author":"SJ Yu","year":"2023","unstructured":"Yu SJ (2023) Immunotherapy for hepatocellular carcinoma: recent advances and future targets. Pharmacol Ther. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108387","journal-title":"Pharmacol Ther"},{"key":"4164_CR9","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cell.2020.11.041","volume":"184","author":"Y Sun","year":"2021","unstructured":"Sun Y, Wu L, Zhong Y et al (2021) Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma. Cell 184:404-421.e16. https:\/\/doi.org\/10.1016\/j.cell.2020.11.041","journal-title":"Cell"},{"key":"4164_CR10","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","volume":"169","author":"C Zheng","year":"2017","unstructured":"Zheng C, Zheng L, Yoo J-K et al (2017) Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing. Cell 169:1342-1356.e16. https:\/\/doi.org\/10.1016\/j.cell.2017.05.035","journal-title":"Cell"},{"key":"4164_CR11","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/cam4.4537","volume":"11","author":"T Irie","year":"2022","unstructured":"Irie T, Yoshii D, Komohara Y et al (2022) Il-34 in hepatoblastoma cells potentially promote tumor progression via autocrine and paracrine mechanisms. Cancer Med 11:1441\u20131453. https:\/\/doi.org\/10.1002\/cam4.4537","journal-title":"Cancer Med"},{"key":"4164_CR12","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1038\/s41467-022-32473-z","volume":"13","author":"H Song","year":"2022","unstructured":"Song H, Bucher S, Rosenberg K et al (2022) Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids. Nat Commun 13:4878. https:\/\/doi.org\/10.1038\/s41467-022-32473-z","journal-title":"Nat Commun"},{"key":"4164_CR13","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1158\/2159-8290.CD-20-1809","volume":"11","author":"TZ Hirsch","year":"2021","unstructured":"Hirsch TZ, Pilet J, Morcrette G et al (2021) Integrated genomic analysis identifies driver genes and Cisplatin-resistant progenitor phenotype in pediatric liver cancer. Cancer Discov 11:2524\u20132543. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-1809","journal-title":"Cancer Discov"},{"key":"4164_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101044","volume":"4","author":"Y Wang","year":"2023","unstructured":"Wang Y, Xiang X, Chen H et al (2023) Intratumoral erythroblastic islands restrain anti-tumor immunity in hepatoblastoma. Cell Rep Med 4:101044. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101044","journal-title":"Cell Rep Med"},{"key":"4164_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2025.01.031","author":"D M\u00fcnter","year":"2025","unstructured":"M\u00fcnter D, de Faria FW, Richter M et al (2025) Multiomic analysis uncovers a continuous spectrum of differentiation and Wnt-MDK-driven immune evasion in hepatoblastoma. J Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2025.01.031","journal-title":"J Hepatol"},{"key":"4164_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-025-03137-8","author":"S Van Dam","year":"2025","unstructured":"Van Dam S, Krijgsman D, K\u00fc\u00e7\u00fckk\u00f6se E et al (2025) Anti-PD-1 treatment response isassociated with the influx of circulating myeloid and T-cell subsets into the metastatic melanoma tumor microenvironment. Br J Cancer. https:\/\/doi.org\/10.1038\/s41416-025-03137-8","journal-title":"Br J Cancer"},{"key":"4164_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12915-021-01043-y","volume":"19","author":"MJD Baars","year":"2021","unstructured":"Baars MJD, Sinha N, Amini M et al (2021) MATISSE: a method for improved single cell segmentation in imaging mass cytometry. BMC Biol 19:99. https:\/\/doi.org\/10.1186\/s12915-021-01043-y","journal-title":"BMC Biol"},{"key":"4164_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.101034","volume":"3","author":"D Krijgsman","year":"2022","unstructured":"Krijgsman D, Sinha N, Baars MJD et al (2022) MATISSE: an analysis protocol for combining imaging mass cytometry with fluorescence microscopy to generate single-cell data. STAR Protoc 3:101034. https:\/\/doi.org\/10.1016\/j.xpro.2021.101034","journal-title":"STAR Protoc"},{"issue":"3","key":"4164_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107523","volume":"31","author":"CR Stoltzfus","year":"2020","unstructured":"Stoltzfus CR, Filipek J, Gern BH et al (2020) CytoMAP: a spatial analysis toolbox reveals features of myeloid cell organization in Lymphoid Tissues. Cell Rep 31(3):107523","journal-title":"Cell Rep"},{"key":"4164_CR20","doi-asserted-by":"publisher","first-page":"8576","DOI":"10.1038\/s41467-024-52757-w","volume":"15","author":"TA Kluiver","year":"2024","unstructured":"Kluiver TA, Lu Y, Schubert SA et al. Divergent WNT signaling and drug sensitivity profiles within hepatoblastoma tumors and organoids. Nat Commun 15, 8576 (2024)","journal-title":"Nat Commun"},{"key":"4164_CR21","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E et al (2021) Integrated analysis of multimodal single-cell data. Cell 184:3573-3587.e29. https:\/\/doi.org\/10.1016\/j.cell.2021.04.048","journal-title":"Cell"},{"key":"4164_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13059-020-1950-6","volume":"21","author":"S Yang","year":"2020","unstructured":"Yang S, Corbett SE, Koga Y et al (2020) Decontamination of ambient RNA in single-cell RNA-seq with DecontX. Genome Biol 21:57. https:\/\/doi.org\/10.1186\/s13059-020-1950-6","journal-title":"Genome Biol"},{"key":"4164_CR23","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/s41467-020-15155-6","volume":"11","author":"C Calandrini","year":"2020","unstructured":"Calandrini C, Schutgens F, Oka R et al (2020) An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity. Nat Commun 11:1310. https:\/\/doi.org\/10.1038\/s41467-020-15155-6","journal-title":"Nat Commun"},{"key":"4164_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abf7777","author":"SA Dick","year":"2022","unstructured":"Dick SA, Wong A, Hamidzada H et al (2022) Three tissue resident macrophage subsets coexist across organs with conserved origins and life cycles. Sci Immunol. https:\/\/doi.org\/10.1126\/sciimmunol.abf7777","journal-title":"Sci Immunol"},{"key":"4164_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1109\/MC.1983.1654163","volume":"16","author":"Sternberg","year":"1983","unstructured":"Sternberg (1983) Biomedical image processing. Computer (Long Beach Calif) 16:22\u201334. https:\/\/doi.org\/10.1109\/MC.1983.1654163","journal-title":"Computer (Long Beach Calif)"},{"key":"4164_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","volume":"18","author":"C Stringer","year":"2021","unstructured":"Stringer C, Wang T, Michaelos M, Pachitariu M (2021) Cellpose: a generalist algorithm for cellular segmentation. Nat Methods 18:100\u2013106. https:\/\/doi.org\/10.1038\/s41592-020-01018-x","journal-title":"Nat Methods"},{"key":"4164_CR27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1165\/ajrcmb\/2.4.335","volume":"2","author":"VL Shepherd","year":"1990","unstructured":"Shepherd VL, Hoidal JR (1990) Clearance of neutrophil-derived myeloperoxidase by the macrophage mannose receptor. Am J Respir Cell Mol Biol 2:335\u2013340. https:\/\/doi.org\/10.1165\/ajrcmb\/2.4.335","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4164_CR28","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.4049\/jimmunol.1800159","volume":"203","author":"B Lazzaretto","year":"2019","unstructured":"Lazzaretto B, Fadeel B (2019) Intra- and extracellular degradation of neutrophil extracellular traps by macrophages and dendritic cells. J Immunol 203:2276\u20132290. https:\/\/doi.org\/10.4049\/jimmunol.1800159","journal-title":"J Immunol"},{"key":"4164_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2022.101369","volume":"32","author":"K Sri-ngern-ngam","year":"2022","unstructured":"Sri-ngern-ngam K, Keawvilai P, Pisitkun T, Palaga T (2022) Upregulation of programmed cell death 1 by interferon gamma and its biological functions in human monocytes. Biochem Biophys Rep 32:101369. https:\/\/doi.org\/10.1016\/j.bbrep.2022.101369","journal-title":"Biochem Biophys Rep"},{"key":"4164_CR30","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.4049\/jimmunol.1402550","volume":"194","author":"APR Bally","year":"2015","unstructured":"Bally APR, Lu P, Tang Y et al (2015) NF-\u03bab regulates PD-1 expression in macrophages. J Immunol 194:4545\u20134554. https:\/\/doi.org\/10.4049\/jimmunol.1402550","journal-title":"J Immunol"},{"key":"4164_CR31","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng S, Li Z, Gao R et al (2021) A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell 184:792-809.e23. https:\/\/doi.org\/10.1016\/j.cell.2021.01.010","journal-title":"Cell"},{"key":"4164_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02371-y","author":"Y Chu","year":"2023","unstructured":"Chu Y, Dai E, Li Y et al (2023) Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance. Nat Med. https:\/\/doi.org\/10.1038\/s41591-023-02371-y","journal-title":"Nat Med"},{"key":"4164_CR33","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1038\/s41467-021-23324-4","volume":"12","author":"M Andreatta","year":"2021","unstructured":"Andreatta M, Corria-Osorio J, M\u00fcller S et al (2021) Interpretation of T cell states from single-cell transcriptomics data using reference atlases. Nat Commun 12:2965. https:\/\/doi.org\/10.1038\/s41467-021-23324-4","journal-title":"Nat Commun"},{"key":"4164_CR34","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","volume":"179","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, He Y, Luo N et al (2019) Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell 179:829-845.e20. https:\/\/doi.org\/10.1016\/j.cell.2019.10.003","journal-title":"Cell"},{"key":"4164_CR35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.cell.2020.08.040","volume":"183","author":"A Sharma","year":"2020","unstructured":"Sharma A, Seow JJW, Dutertre C-A et al (2020) Onco-fetal reprogramming of endothelial cells drives immunosuppressive macrophages in hepatocellular carcinoma. Cell 183:377-394.e21. https:\/\/doi.org\/10.1016\/j.cell.2020.08.040","journal-title":"Cell"},{"key":"4164_CR36","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2100070","author":"GK Abou-Alfa","year":"2022","unstructured":"Abou-Alfa GK, Lau G, Kudo M et al (2022) Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma. NEJM Evid. https:\/\/doi.org\/10.1056\/EVIDoa2100070","journal-title":"NEJM Evid"},{"key":"4164_CR37","doi-asserted-by":"publisher","unstructured":"Long AH, Morgenstern DA, Leruste A et al (2022) Checkpoint immunotherapy in pediatrics: here, gone, and back again. American Society of Clinical Oncology Educational Book. pp 781\u2013794 https:\/\/doi.org\/10.1200\/EDBK_349799","DOI":"10.1200\/EDBK_349799"},{"key":"4164_CR38","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s00795-022-00323-y","volume":"55","author":"L Li","year":"2022","unstructured":"Li L, Irie T, Yoshii D et al (2022) M-CSFR expression in the embryonal component of hepatoblastoma and cell-to-cell interaction between macrophages and hepatoblastoma. Med Mol Morphol 55:236\u2013247. https:\/\/doi.org\/10.1007\/s00795-022-00323-y","journal-title":"Med Mol Morphol"},{"key":"4164_CR39","doi-asserted-by":"publisher","first-page":"25139","DOI":"10.1074\/jbc.M112.353060","volume":"287","author":"S Lohse","year":"2012","unstructured":"Lohse S, Brunke C, Derer S et al (2012) Characterization of a mutated IgA2 antibody of the m(1) allotype against the epidermal growth factor receptor for the recruitment of monocytes and macrophages. J Biol Chem 287:25139\u201325150. https:\/\/doi.org\/10.1074\/jbc.M112.353060","journal-title":"J Biol Chem"},{"issue":"7","key":"4164_CR40","first-page":"e006948","volume":"11","author":"M Stip","year":"2023","unstructured":"Stip M et al (2023) IgA antibody immunotherapy targeting GD2 is effective in preclinical neuroblastoma models. JITC 11(7):e006948","journal-title":"JITC"},{"key":"4164_CR41","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.7314\/APJCP.2015.16.3.1029","volume":"16","author":"X-L Xiong","year":"2015","unstructured":"Xiong X-L, Qin H, Yan S-Q et al (2015) Expression of Glypican-3 is highly associated with pediatric hepatoblastoma: a systemic analysis. Asian Pac J Cancer Prev 16:1029\u20131031. https:\/\/doi.org\/10.7314\/APJCP.2015.16.3.1029","journal-title":"Asian Pac J Cancer Prev"},{"key":"4164_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.824208","author":"X Zheng","year":"2022","unstructured":"Zheng X, Liu X, Lei Y et al (2022) Glypican-3: a novel and promising target for the treatment of hepatocellular carcinoma. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2022.824208","journal-title":"Front Oncol"},{"key":"4164_CR43","doi-asserted-by":"publisher","first-page":"33878","DOI":"10.1038\/srep33878","volume":"6","author":"Y-F Zhang","year":"2016","unstructured":"Zhang Y-F, Ho M (2016) Humanization of high-affinity antibodies targeting glypican-3 in hepatocellular carcinoma. Sci Rep 6:33878. https:\/\/doi.org\/10.1038\/srep33878","journal-title":"Sci Rep"},{"key":"4164_CR44","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12967-020-02462-1","volume":"18","author":"X Liu","year":"2020","unstructured":"Liu X, Gao F, Jiang L et al (2020) 32A9, a novel human antibody for designing an immunotoxin and CAR-T cells against glypican-3 in hepatocellular carcinoma. J Transl Med 18:295. https:\/\/doi.org\/10.1186\/s12967-020-02462-1","journal-title":"J Transl Med"},{"key":"4164_CR45","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/s41586-024-08261-8","volume":"637","author":"D Steffin","year":"2025","unstructured":"Steffin D, Ghatwai N, Montalbano A et al (2025) Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers. Nature 637:940\u2013946. https:\/\/doi.org\/10.1038\/s41586-024-08261-8","journal-title":"Nature"},{"key":"4164_CR46","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jconrel.2023.07.021","volume":"360","author":"Z Yang","year":"2023","unstructured":"Yang Z, Liu Y, Zhao K et al (2023) Dual mRNA co-delivery for in situ generation of phagocytosis-enhanced CAR macrophages augments hepatocellular carcinoma immunotherapy. J Control Release 360:718\u2013733. https:\/\/doi.org\/10.1016\/j.jconrel.2023.07.021","journal-title":"J Control Release"},{"key":"4164_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9111596","author":"K Zubair","year":"2021","unstructured":"Zubair K, You C, Kwon G, Kang K (2021) Two faces of macrophages: training and tolerance. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines9111596","journal-title":"Biomedicines"},{"key":"4164_CR48","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2018.09.007","volume":"175","author":"S Su","year":"2018","unstructured":"Su S, Zhao J, Xing Y et al (2018) Immune checkpoint inhibition overcomes ADCP-induced immunosuppression by macrophages. Cell 175:442-457.e23. https:\/\/doi.org\/10.1016\/j.cell.2018.09.007","journal-title":"Cell"},{"key":"4164_CR49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40364-022-00373-5","volume":"10","author":"T Qu","year":"2022","unstructured":"Qu T, Li B, Wang Y (2022) Targeting CD47\/SIRP\u03b1 as a therapeutic strategy, where we are and where we are headed. Biomark Res 10:20. https:\/\/doi.org\/10.1186\/s40364-022-00373-5","journal-title":"Biomark Res"},{"key":"4164_CR50","unstructured":"Kineta Inc (2020) Targeting VISTA to halt tumor growth. Nature research custom media"},{"key":"4164_CR51","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.3390\/biomedicines10081822","volume":"10","author":"MC Merlano","year":"2022","unstructured":"Merlano MC, Denaro N, Galizia D et al (2022) How chemotherapy affects the tumor immune microenvironment: a narrative review. Biomedicines 10:1822. https:\/\/doi.org\/10.3390\/biomedicines10081822","journal-title":"Biomedicines"},{"key":"4164_CR52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nri978","volume":"3","author":"S Gordon","year":"2003","unstructured":"Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3:23\u201335. https:\/\/doi.org\/10.1038\/nri978","journal-title":"Nat Rev Immunol"},{"key":"4164_CR53","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1038\/s41467-020-15404-8","volume":"11","author":"AJ Gunderson","year":"2020","unstructured":"Gunderson AJ, Yamazaki T, McCarty K et al (2020) TGF\u03b2 suppresses CD8+ T cell expression of CXCR3 and tumor trafficking. Nat Commun 11:1749. https:\/\/doi.org\/10.1038\/s41467-020-15404-8","journal-title":"Nat Commun"},{"key":"4164_CR54","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.it.2011.12.001","volume":"33","author":"B Ruffell","year":"2012","unstructured":"Ruffell B, Affara NI, Coussens LM (2012) Differential macrophage programming in the tumor microenvironment. Trends Immunol 33:119\u2013126. https:\/\/doi.org\/10.1016\/j.it.2011.12.001","journal-title":"Trends Immunol"},{"key":"4164_CR55","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","volume":"23","author":"A Mantovani","year":"2002","unstructured":"Mantovani A, Sozzani S, Locati M et al (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23:549\u2013555. https:\/\/doi.org\/10.1016\/S1471-4906(02)02302-5","journal-title":"Trends Immunol"},{"key":"4164_CR56","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1038\/s41467-018-06318-7","volume":"9","author":"SA MacParland","year":"2018","unstructured":"MacParland SA, Liu JC, Ma X-Z et al (2018) Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations. Nat Commun 9:4383. https:\/\/doi.org\/10.1038\/s41467-018-06318-7","journal-title":"Nat Commun"},{"key":"4164_CR57","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41586-019-1373-2","volume":"572","author":"N Aizarani","year":"2019","unstructured":"Aizarani N, Saviano A, Sagar et al (2019) A human liver cell atlas reveals heterogeneity and epithelial progenitors. Nature 572:199\u2013204. https:\/\/doi.org\/10.1038\/s41586-019-1373-2","journal-title":"Nature"},{"key":"4164_CR58","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","volume":"575","author":"P Ramachandran","year":"2019","unstructured":"Ramachandran P, Dobie R, Wilson-Kanamori JR et al (2019) Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature 575:512\u2013518. https:\/\/doi.org\/10.1038\/s41586-019-1631-3","journal-title":"Nature"},{"key":"4164_CR59","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cell.2021.12.018","volume":"185","author":"M Guilliams","year":"2022","unstructured":"Guilliams M, Bonnardel J, Haest B et al (2022) Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches. Cell 185:379-396.e38. https:\/\/doi.org\/10.1016\/j.cell.2021.12.018","journal-title":"Cell"},{"key":"4164_CR60","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1016\/j.cell.2022.10.007","volume":"185","author":"MD Park","year":"2022","unstructured":"Park MD, Silvin A, Ginhoux F, Merad M (2022) Macrophages in health and disease. Cell 185:4259\u20134279. https:\/\/doi.org\/10.1016\/j.cell.2022.10.007","journal-title":"Cell"},{"key":"4164_CR61","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.immuni.2020.08.004","volume":"53","author":"A Remmerie","year":"2020","unstructured":"Remmerie A, Martens L, Thon\u00e9 T et al (2020) Osteopontin expression identifies a subset of recruited macrophages distinct from Kupffer cells in the fatty liver. Immunity 53:641-657.e14. https:\/\/doi.org\/10.1016\/j.immuni.2020.08.004","journal-title":"Immunity"},{"key":"4164_CR62","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1002\/ijc.34505","volume":"152","author":"B Van der Borght","year":"2023","unstructured":"Van der Borght B, De Muynck K, Gijbels E et al (2023) Transient Kupffer cell depletion and subsequent replacement by infiltrating monocyte-derived cells does not alter the induction or progression of hepatocellular carcinoma. Int J Cancer 152:2615\u20132628. https:\/\/doi.org\/10.1002\/ijc.34505","journal-title":"Int J Cancer"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04164-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-025-04164-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04164-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:01:49Z","timestamp":1760821309000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-025-04164-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,13]]},"references-count":62,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["4164"],"URL":"https:\/\/doi.org\/10.1007\/s00262-025-04164-3","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,13]]},"assertion":[{"value":"4 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yvonne Vercoulen declares a speaker\u2019s fee from Johnson & Johnson, and funding from AlfaSigma and TigaTx B.V. Jeanette Leusen is the scientific founder and shareholder of TigaTx. Weng Chuan Peng and Jeanette Leusen are supported by Oncode Accelerator, a Dutch National Growth Fund project, under grant number NGFOP2201.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"310"}}